We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Drugmaker does not specify reason but forex shortage has put pressure on multinationals
Legal and regulatory actions are more likely to drag on earnings than negate them
Novo Nordisk and Eli Lilly accused of failing to warn patients of gastroparesis risk
Chemify’s technology aims to remove bottleneck of producing molecules in the lab
Drugmaker reports 38% jump in earnings as it expands genomic medicine business
Drugmaker projects rise in revenue of up to 10% after consensus-beating second quarter
New chief needs to signal to investors whether a restructuring is likely
Pharma industry deprioritising certain pills with shorter exclusivity period, says head of Swiss drugmaker
Promising trial results will not end scientific debate over the disease, but they further validate pharmaceutical research
Swiss drugmaker says potential deals not attractive enough to pursue
Dementia experts hail ‘watershed moment’ after trial results for donanemab antibody treatment
Illumina-owned cancer testing group allegedly failed to deal with accusations of inappropriate behaviour and racism
Food and Drug Administration’s decision is significant development in nationwide battle over reproductive rights
US gene sequencing company proceeded with acquisition of cancer test developer even as regulators were probing deal
We have a narrow window during which to harness AI for good, rather than ill
Move by Food and Drug Administration paves way for millions of Americans to access medicine
Medicines produced by pharma group will be for domestic use only
World’s biggest gene sequencing group closed deal with cancer screening start-up despite ongoing investigation
Trial studied patients with advanced non-small cell lung cancer
A decade ago a large part of Big Pharma gave up on one of humanity’s cruellest diseases. But then a new treatment showed promise
Successful pilot in England will be expanded to more pharma companies and include N Ireland, Scotland and Wales
New treatments have had remarkable results but there are reasons to be cautious
Massachusetts police chief and former pharmaceutical executive also among those indicted by federal prosecutors
Large-scale study will test GSK’s jab in 26,000 people in Africa and south-east Asia
Insilico Medicine says trial of lung disease therapy is milestone for generative AI in drug development
UK Edition